Aaron Y Chang
6PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 04, 2023
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML.Tao Dao, Guangyan Xiong, Sung Soo Mun
|Dec 31, 2021
Engineering CAR-T cells to activate small-molecule drugs in situ.Thomas J Gardner, J Peter Lee, Christopher M Bourne
|Mar 19, 2020
Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform.Ron S Gejman, Heather F Jones, Martin G Klatt
|Jan 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.Patrizia Mondello, Saber Tadros, Matt Teater
|Sep 22, 2019
ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.Claire Y Oh, Martin G Klatt, Christopher Bourne
|Dec 01, 2018
Rejection of immunogenic tumor clones is limited by clonal fraction.Ron S Gejman, Aaron Y Chang, Heather F Jones
Pageof 1
Frequent Collaborators
2 joint publications
Ron S Gejman
2 joint publications
Heather F Jones
2 joint publications
David A Scheinberg
2 joint publications
Martin G Klatt
2 joint publications
Tatyana Korontsvit
1 joint publications
Abraham Ari Hakimi
1 joint publications
Elliott J Brea
1 joint publications
Patrizia Mondello
1 joint publications
Saber Tadros
1 joint publications
Matt Teater
